Rare diseases
Investigational molecules
Locations
Back to Poland33 clinical trials in Grodzisk Mazowiecki, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
PolandStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PolandStudy on the Effectiveness of Ketoanalogues in Preventing Muscle Loss in Patients with Nephrotic Syndrome
PolandSafety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease
PolandEfficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study
PolandStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
PolandStudy on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis
PolandPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
PolandStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
PolandSafety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE
PolandA study to evaluate the effectiveness of levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction.
PolandA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
PolandThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials exploring treatments for atherosclerotic cardiovascular disease and stroke prevention. Studies focus on innovative therapies for heart failure and post-myocardial infarction care.
Researchers are evaluating novel compounds like asundexian and obicetrapib for improving cardiovascular outcomes.
Comprehensive studies investigating treatments for various autoimmune disorders, including psoriatic arthritis and multiple sclerosis. Research focuses on targeted therapies and disease-modifying treatments.
Novel biologics and immunomodulators are being tested to improve patient outcomes.
Innovative research into treatments for chronic obstructive pulmonary disease, examining new therapeutic approaches for managing moderate to severe cases.
Studies evaluate medications like tezepelumab and benralizumab for improving respiratory outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
